Antimicrobial and immunomodulatory potential of various Lactobacillus reuteri strains is closely connected to their metabolite production profile under given cultivation conditions. We determined the in vitro production of antimicrobial substances such as organic acids, ethanol, and reuterin by four strains of L. reuteri (L. reuteri E, L. reuteri KO5, L. reuteri CCM 3625, and L. reuteri ATCC 55730). All studied L. reuteri strains showed the ability to produce lactic acid, acetic acid, and ethanol with concominant consumption of glucose and together with phenyllactic acid-a potent antifungal compound-with concominant consumption of phenylalanine. The reuterin production from glycerol was confirmed for all analyzed lactobacilli strains except L. reuteri CCM 3625. Production of organic acids, ethanol, and reuterin is significantly involved in antimicrobial activity of lactobacilli which was determined using the dual-culture overlay diffusion method against six indicator bacteria and five indicator moulds. In comparison to the referential L. reuteri ATCC 55730, the highest inhibition potential was observed against Escherichia coli CCM 3988 and Pseudomonas aeruginosa CCM 3955. Among analyzed indicators of moulds, the growth of Alternaria alternata CCM F-128 was the most inhibited by all four analyzed L. reuteri strains. Finally, the immunomodulatory potential of analyzed lactobacilli were proven by the determination of the in vitro production of biogenic amines histamine and tyramine. L. reuteri CCM 3625 was able to produce tyramine, and L. reuteri E and L. reuteri KO5 were able to produce histamine under given cultivation conditions.

Department of Cellular and Molecular Biology of Drugs Faculty of Pharmacy Comenius University Odbojárov 10 832 32 Bratislava Slovak Republic

Faculty of Chemical and Food Technology Department of Food Technology Slovak University of Technology Radlinského 9 812 37 Bratislava Slovak Republic

Zobrazit více v PubMed

Mol Microbiol. 2004 Sep;53(5):1331-42 PubMed

Biotechnol Lett. 2007 Apr;29(4):593-7 PubMed

Microbiology. 2010 Jun;156(Pt 6):1589-99 PubMed

Folia Microbiol (Praha). 2013 Jan;58(1):33-8 PubMed

Genome Biol Evol. 2014 Jun 19;6(7):1772-89 PubMed

Appl Environ Microbiol. 1990 Apr;56(4):1195-7 PubMed

Front Microbiol. 2012 May 28;3:180 PubMed

Appl Environ Microbiol. 1990 Jun;56(6):1875-81 PubMed

J Bacteriol. 2008 Jan;190(1):206-12 PubMed

Microb Cell Fact. 2011 Aug 30;10 Suppl 1:S17 PubMed

DNA Res. 2008 Jun 30;15(3):151-61 PubMed

Biochim Biophys Acta. 2010 Nov;1801(11):1175-83 PubMed

Anaerobe. 2008 Jun;14(3):166-71 PubMed

Appl Microbiol Biotechnol. 2012 Sep;95(5):1155-63 PubMed

Int J Food Microbiol. 1996 Apr;29(2-3):213-31 PubMed

PLoS One. 2012;7(2):e31951 PubMed

FEMS Microbiol Lett. 2003 Feb 14;219(1):129-35 PubMed

N Biotechnol. 2012 Jan 15;29(2):211-7 PubMed

Contraception. 2006 Jan;73(1):78-81 PubMed

Int J Food Microbiol. 2009 Apr 30;131(1):30-9 PubMed

J Basic Microbiol. 2011 Jun;51(3):263-8 PubMed

Am J Obstet Gynecol. 2001 Aug;185(2):375-9 PubMed

Appl Microbiol Biotechnol. 2016 Feb;100(4):1701-11 PubMed

Biomed Environ Sci. 2008 Oct;21(5):365-71 PubMed

Antonie Van Leeuwenhoek. 1983 Sep;49(3):209-24 PubMed

Food Chem. 2014 Nov 1;162:172-5 PubMed

J Appl Microbiol. 2015 Sep;119(3):763-75 PubMed

BMC Res Notes. 2013 Nov 14;6:464 PubMed

Antioxid Redox Signal. 2014 Mar 1;20(7):1126-67 PubMed

J Leukoc Biol. 2013 Mar;93(3):387-94 PubMed

BMC Microbiol. 2007 Nov 12;7:101 PubMed

Food Microbiol. 2014 Dec;44:271-7 PubMed

Int J Food Microbiol. 2010 Oct 15;143(3):87-102 PubMed

J Bacteriol. 1993 May;175(10):2864-70 PubMed

Appl Microbiol Biotechnol. 2002 Jul;59(2-3):289-96 PubMed

Int J Food Microbiol. 2014 Mar 3;173:30-5 PubMed

Appl Environ Microbiol. 2003 Jan;69(1):634-40 PubMed